Peripheral blood: no significant difference between MS and HD in CD20+CD3+ frequency (2–6%) and CD4+CD20+:CD8+CD20+ ratio.↑ proportion of CD20+ T cells secreted IFN-γ compared to CD20− ones (97.9% vs. 11.8%, respectively). The gene discussed is MS4A1; the disease is myeloid sarcoma.